New Zealand markets closed

Spruce Biosciences, Inc. (SPRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7362-0.0273 (-3.58%)
At close: 04:00PM EDT
0.7400 +0.00 (+0.52%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 30.30M
Enterprise value -61.43M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.81
Price/book (mrq)0.40
Enterprise value/revenue -6.09
Enterprise value/EBITDA 1.30

Trading information

Stock price history

Beta (5Y monthly) 2.53
52-week change 3-63.38%
S&P500 52-week change 323.42%
52-week high 35.9500
52-week low 30.6790
50-day moving average 33.1099
200-day moving average 32.2989

Share statistics

Avg vol (3-month) 31.3M
Avg vol (10-day) 3737.15k
Shares outstanding 541.15M
Implied shares outstanding 641.15M
Float 813.54M
% held by insiders 17.75%
% held by institutions 171.24%
Shares short (28 Mar 2024) 4320.39k
Short ratio (28 Mar 2024) 40.11
Short % of float (28 Mar 2024) 40.82%
Short % of shares outstanding (28 Mar 2024) 40.78%
Shares short (prior month 29 Feb 2024) 433.68k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-386.70%

Management effectiveness

Return on assets (ttm)-34.28%
Return on equity (ttm)-66.10%

Income statement

Revenue (ttm)10.09M
Revenue per share (ttm)0.26
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -51.92M
Net income avi to common (ttm)-47.92M
Diluted EPS (ttm)-1.2400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)96.34M
Total cash per share (mrq)2.34
Total debt (mrq)4.61M
Total debt/equity (mrq)6.02%
Current ratio (mrq)4.18
Book value per share (mrq)1.87

Cash flow statement

Operating cash flow (ttm)-33.27M
Levered free cash flow (ttm)-17.52M